Ventas, Inc. with ticker code (VTR) now have 18 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $61.00 and $46.00 suggesting an average analyst share price target price of $52.00. (at the time of writing). Now with the previous closing price of $42.48 and the analysts are correct then we can expect a percentage increase in value of 22.4%. The 50 day moving average now sits at $45.50 and the 200 day moving average is $45.22. The market cap for the company is 17.21B. The stock price is currently at: $42.77 USD
The potential market cap would be $21,070,895,440 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of $11.20 and a 1.65% return on assets.
Ventas, Inc. is a real estate investment trust (REIT). The Company is engaged in operating at the intersection of healthcare and real estate. It has a portfolio of senior housing communities, medical office buildings (MOBs), life science, research and innovation centers, hospitals and other healthcare facilities. The Company’s segments include Triple-Net Leased Properties, Senior Housing Operating Portfolio (SHOP), and Office Operations. Triple-Net Leased Properties is engaged in investing in and owning senior housing and healthcare properties throughout the United States and the United Kingdom and leasing those properties to healthcare operating companies under triple-net or absolute-net leases. The Senior Housing Operating Portfolio (SHOP) segment invests in senior housing communities throughout the United States and Canada. The Office Operations segment acquires, owns, develops, leases and manages MOBs and life science, research and innovation centers throughout the United States.
